ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,285
0,00%
Bitcoin
97 820,19
-0,87%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Cocrystal Pharma Inc (COCP) Cours

Cocrystal Pharma Inc

Cocrystal Pharma Inc (COCP)

NASDAQ
2,52
-0,17
(-6,32%)
Fermé 25 Décembre 10:00PM
Retardé de 15 minutes
2,52
0,00
(0,00%)
Après les heures de négociation: 11:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
2,52
Prix Achat
2,42
Prix Vente
2,70
Volume échangé
36 706
2,3901 Fourchette du Jour 2,75
1,325 Plage de 52 semaines 3,10
Cap du marché
25,638M
Clôture Veille
2,69
Ouverture
2,73
Dernière Transaction
100
@
2.52
(formt)
Dernière heure de transaction
Volume financier
US$ 94 090
VWAP
2,5633
Volume moyen (3 m)
23 769
Actions en circulation
10 173 790
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,43
Bénéfice par action (BPA)
-1,77
Chiffre d'affairess
2,6M
Bénéfice net
-17,98M

À propos de Cocrystal Pharma Inc

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.cocrystalpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Cocrystal Pharma Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker COCP. Le dernier cours de clôture d'Cocrystal Pharma était de US$2,69. Au cours de la dernière année, les actions de Cocrystal Pharma ont été négociées dans une fourchette de prix de US$ 1,325 à US$ 3,10.

Cocrystal Pharma compte actuellement 10 173 790 actions en circulation. La capitalisation boursière d'Cocrystal Pharma est de US$27,37 million. Cocrystal Pharma a un ratio cours/bénéfice (ratio PE) de -1.43.

COCP Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

13 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Novembre 2024
Edgar (US Regulatory)

Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30...

13 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

31 Octobre 2024
Edgar (US Regulatory)

Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins

The Company’s antiviral candidate for seasonal and pandemic influenza shows in vitro activity against the avian influenza A PB2 protein, whereas current influenza vaccines offer no protection...

31 Octobre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

11 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Octobre 2024
Edgar (US Regulatory)

Form 8-K - Current report

10 Octobre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.4722.92682926832.052.691.9758062.3701269CS
40.311914.12526606582.20812.691.81307152.2294056CS
120.7945.66473988441.732.691.65237692.06862168CS
26-0.17-6.319702602232.692.78041.6216552.06134236CS
520.7340.7821229051.793.11.325215652.00276869CS
156-6.18-71.03448275868.78.881.3251066385.07880399CS
260-2.64-51.16279069775.1649.21.325202669618.89237513CS

COCP - Frequently Asked Questions (FAQ)

What is the current Cocrystal Pharma share price?
The current share price of Cocrystal Pharma is US$ 2,52
How many Cocrystal Pharma shares are in issue?
Cocrystal Pharma has 10 173 790 shares in issue
What is the market cap of Cocrystal Pharma?
The market capitalisation of Cocrystal Pharma is USD 27,37M
What is the 1 year trading range for Cocrystal Pharma share price?
Cocrystal Pharma has traded in the range of US$ 1,325 to US$ 3,10 during the past year
What is the PE ratio of Cocrystal Pharma?
The price to earnings ratio of Cocrystal Pharma is -1,43
What is the cash to sales ratio of Cocrystal Pharma?
The cash to sales ratio of Cocrystal Pharma is 9,86
What is the reporting currency for Cocrystal Pharma?
Cocrystal Pharma reports financial results in USD
What is the latest annual turnover for Cocrystal Pharma?
The latest annual turnover of Cocrystal Pharma is USD 2,6M
What is the latest annual profit for Cocrystal Pharma?
The latest annual profit of Cocrystal Pharma is USD -17,98M
What is the registered address of Cocrystal Pharma?
The registered address for Cocrystal Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Cocrystal Pharma website address?
The website address for Cocrystal Pharma is www.cocrystalpharma.com
Which industry sector does Cocrystal Pharma operate in?
Cocrystal Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7,10
(310,40%)
58,74M
HOURHour Loop Inc
US$ 4,40
(207,69%)
97,42M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
CREVCarbon Revolution Public Ltd
US$ 9,16
(135,48%)
26,95M
AVGRAvinger Inc
US$ 1,45
(125,72%)
107,53M
SLGLSol Gel Technologies Ltd
US$ 0,9798
(-40,62%)
3,07M
DRCTDirect Digital Holdings Inc
US$ 3,71
(-32,55%)
23,82M
CHEKCheck Cap Ltd
US$ 1,55
(-31,11%)
3,49M
SYTASiyata Mobile Inc
US$ 0,5178
(-30,83%)
2,63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15,47
(-30,38%)
147,98k
SVMHSRIVARU Holding Ltd
US$ 0,0338
(20,71%)
280,27M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
LITMSnow Lake Resources Ltd
US$ 0,5849
(52,84%)
181,22M
LCIDLucid Group Inc
US$ 3,20
(3,23%)
108,75M
RGTIRigetti Computing Inc
US$ 11,35
(3,56%)
108,38M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
COCP
Cocrystal Pharma
AQSE
XCS6.GB
Deutsche Bank Luxembourg
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés